In conclusion, this study identifies TIM4 as a lung cDC1 phagocytic receptor implicated in immune surveillance of early murine tumors, that is targeted at later stages of tumor progression impairing antitumor responses. This evidence concerns the gene TIMD4 and neoplasm.